Table of Contents

Table of Contents

• 1.1 List of Tables 8
• 1.2 List of Figures 12

2 Introduction 13

• 2.1 Retrovirus Tests Overview 13

Retrovirus Tests are the diagnostic tests used to detect the antigen/antibody of HIV1, HIV 2 (human immunodeficiency virus) and HTLV I, HTLV II (human T-cell lymphotropic virus) viruses. 13

3 Products under Development 14

• 3.1 Retrovirus Tests - Pipeline Products by Stage of Development 14
• 3.2 Retrovirus Tests - Pipeline Products by Segment 15
• 3.3 Retrovirus Tests - Pipeline Products by Territory 16
• 3.4 Retrovirus Tests - Pipeline Products by Regulatory Path 17
• 3.5 Retrovirus Tests - Pipeline Products by Estimated Approval Date 18

4 Retrovirus Tests - Pipeline Products under Development by Companies 19

• 4.1 Retrovirus Tests Companies - Pipeline Products by Stage of Development 19
• 4.2 Retrovirus Tests - Pipeline Products by Stage of Development 22

5 Retrovirus Tests Companies and Product Overview 25

• 5.1 Accelevir Diagnostics LLC Company Overview 25
• 5.2 Advanced Liquid Logic Inc Company Overview 26
• 5.3 Alere Inc Company Overview 27
• 5.4 Allied Innovative Systems, LLC Company Overview 29
• 5.5 Autoimmune Technologies LLC Company Overview 30
• 5.6 Avioq, Inc. Company Overview 31
• 5.7 Ayanda Biosystems SA (Inactive) Company Overview 32
• 5.8 Biokit SA Company Overview 33
• 5.9 Biomagnetics Diagnostics Corp Company Overview 35
• 5.10 Calypte Biomedical Corporation Company Overview 37
• 5.11 CeMines, Inc. (Inactive) Company Overview 38
• 5.12 Cepheid Company Overview 39
• 5.13 ChipCare Corp Company Overview 40
• 5.14 Co-Diagnostics Inc Company Overview 41
• 5.15 Conrad Company Overview 42
• 5.16 Cue Inc. Company Overview 44
• 5.17 Diagnostics for the Real World (Europe) Ltd Company Overview 45
• 5.18 DiaSorin SpA Company Overview 47
• 5.19 DNAE Group Holdings Ltd Company Overview 48
• 5.20 Enable Biosciences Inc Company Overview 49
• 5.21 Enzo Biochem Inc Company Overview 50
• 5.22 ERBA Molecular Ltd Company Overview 51
• 5.23 Eurobio Scientific SA Company Overview 53
• 5.24 Fast Track Diagnostics Ltd. Company Overview 55
• 5.25 Fujirebio Diagnostics Inc Company Overview 56
• 5.26 Genome Diagnostics Pvt. Ltd. Company Overview 59
• 5.27 Immunetics Inc Company Overview 61
• 5.28 Institute for Development Research Company Overview 62
• 5.29 IRIS International Inc Company Overview 63
• 5.30 Jan Biotech Inc Company Overview 64
• 5.31 Johns Hopkins University Company Overview 65
• 5.32 MedMira Inc Company Overview 66
• 5.33 MedNostic Technologies, LLC Company Overview 67
• 5.34 MND Diagnostic LTD Company Overview 68
• 5.35 Molecular Testing Labs Company Overview 69
• 5.36 Monogram Biosciences Inc Company Overview 70
• 5.37 Odyssey Thera, inc. (Inactive) Company Overview 71
• 5.38 Oregon Health & Science University Company Overview 72
• 5.39 Ortho-Clinical Diagnostics Inc Company Overview 73
• 5.40 Paramedical Srl Company Overview 76
• 5.41 Pathogenica Inc Company Overview 77
• 5.42 PATHseq Diagnostics Inc Company Overview 78
• 5.43 PixCell Medical Technologies Ltd Company Overview 79
• 5.44 Purdue University Company Overview 80
• 5.45 Rice University Company Overview 81
• 5.46 Roche Diagnostics International Ltd Company Overview 82
• 5.47 Sansure Biotech Inc Company Overview 87
• 5.48 Seattle Children's Hospital Company Overview 88
• 5.49 Seegene Inc Company Overview 89
• 5.50 Shenzhen New Industries Biomedical Engineering Co Ltd Company Overview 90
• 5.51 Siemens Healthcare Diagnostics Inc Company Overview 91
• 5.52 Siemens Healthineers AG Company Overview 92
• 5.53 Syamala Srinivasa Life Sciences Pvt. Ltd Company Overview 93
• 5.54 TheraDiag SA Company Overview 94
• 5.55 TrovaGene Inc Company Overview 96
• 5.56 University of California San Diego Company Overview 97
• 5.57 University of Washington Company Overview 98
• 5.58 Ustar Biotechnologies (Hangzhou) Ltd. Company Overview 99
• 5.59 VEGA Ltd Company Overview 100

6 Retrovirus Tests- Recent Developments 101

• 6.1 Nov 07, 2019: Trovagene announces third quarter 2019 results and highlights 101
• 6.2 Nov 06, 2019: USFDA authorises marketing of Sentosa SQ HIV Genotyping Assay 103
• 6.3 Nov 06, 2019: LabCorp announces Departure of John Ratliff, names New LabCorp Diagnostics leadershin 104
• 6.4 Nov 06, 2019: OraSure announces 2019 third quarter financial results 104
• 6.5 Nov 06, 2019: Hologic announces financial results for fourth quarter of fiscal 2019 106
• 6.6 Nov 05, 2019: FDA drants De Novo designation to Vela Diagnostics next generation sequencing HIV-1 genotyping assay 108
• 6.7 Nov 05, 2019: BD announces results for 2019 fourth fiscal quarter and full year; provides fiscal 2020 guidance 108
• 6.8 Nov 05, 2019: OPKO Health reports 2019 third quarter business highlights and financial results 110
• 6.9 Nov 04, 2019: Quotient reports second quarter fiscal 2020 financial results 111
• 6.10 Oct 31, 2019: Bio-Rad reports third-quarter 2019 financial results 113

7 Appendix 314

• 7.1 Methodology 314
• 7.2 About GlobalData 317
• 7.3 Contact Us 317

Retrovirus Tests - Medical Devices Pipeline Assessment, 2019

Summary

GlobalData's Medical Devices sector report, “Retrovirus Tests - Medical Devices Pipeline Assessment, 2019" provides an overview of Retrovirus Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Retrovirus Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Retrovirus Tests under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Retrovirus Tests and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Retrovirus Tests under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date